智通财经APP获悉，浙商证券发布研报称，AI医疗应用在国家战略与市场需求的共振下已迈入商业化落 地的快速阶段。该行认为AI制药核心价值在于大幅提升药物早研效率，看好国内多家AI制药平台服务 能力全球领先。AI制药的高需求将带来较大的落地验证实验及合作需求，建议关注已与AI制药平台有 战略合作的传统CRO公司。此外，早研效率大幅提升将快速传导至临床前、安评以及临床CRO需求。 浙商证券主要观点如下： 该行认为AI制药核心价值在于大幅提升药物早研效率，以英矽智能Pharma.AI为例，其能够使候选药物 从靶点发现到临床前候选药物确认时间从4.5年大幅缩短到12至18个月，早研阶段的投入产出比大幅提 升。该行看好：1)国内多家AI制药平台服务能力全球领先，海外业务拓展持续高速已验证，关注英矽智 能、晶泰科技、泓博医药、维亚生物、成都先导等;2)AI制药的高需求将带来较大的落地验证实验及合 作需求，建议关注已与AI制药平台有战略合作的传统CRO公司，关注皓元医药、美迪西、百诚医药、 阳光诺和、药石科技、药明康德等;3)早研效率大幅提升将快速传导至临床前、安评以及临床CRO需 求，建议关注昭衍新药、美迪西、益诺思、泰格 ...

智通财经APP讯，合富中国(603122.SH)发布公告，公司2025年1-12月合并营业收入人民币6.89亿元，较 去年同期下降26.67%。 ...

Group 1 - The medical ETF (159828) rose over 2% during intraday trading, driven by policy cycles and industry recovery [1] - The development of pan-RAS/KRAS inhibitors is expected to cover more mutation types and potentially overcome resistance issues, with KRAS being a major gene mutation in human cancers (81%) [1] - Revolution's pan-RAS inhibitor RMC-6236 has shown efficacy and controllable safety in Phase 1 clinical trials for pancreatic ductal carcinoma patients and is currently in Phase 3 clinical trials [1] Group 2 - There has been a slight increase in medical financing in the CXO and upstream sectors, with BD transactions and H-share IPOs reviving innovation enthusiasm, and the order side showing signs of recovery [1] - External CXO demand is growing, while internal CXO orders are also recovering, suggesting a positive trend in the sector [1] - The medical device industry is currently under pressure due to policy impacts, but improvements in fundamentals are expected with the introduction of anti-involution policies, clearing of centralized procurement, and corporate innovation upgrades [1] Group 3 - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the medical device, medical services, and medical information sectors from the A-share market to reflect the overall performance of Chinese medical theme listed companies [1] - The CSI Medical Index consists of approximately 50 constituent stocks, with a concentration in the pharmaceutical and healthcare sectors [1]

Core Viewpoint - The article highlights the government's initiative to address issues related to the outsourcing of hospital morgues and exorbitant funeral costs, with multiple departments collaborating to implement comprehensive regulations for the management of deceased patients in medical institutions [1] Group 1: Regulatory Changes - The new regulations set clear "red lines" for the services provided by medical institutions regarding deceased patients, aiming to standardize practices and eliminate malpractices [1] - The initiative is a response to widespread concerns about the high costs associated with funeral services and the lack of oversight in morgue outsourcing [1] Group 2: Industry Impact - The regulations are expected to significantly impact the funeral service industry, potentially leading to reduced costs for families and increased accountability for service providers [1] - Medical institutions will need to adapt to these new guidelines, which may involve restructuring their service offerings and pricing strategies [1]

【导读】上午 A 股三大指数集体上涨，商业航天、 Sora 概念股大涨，石油天然气领跌 中国基金报记者 张舟 大家好，新的一周又开始了，基金君和你继续关注市场行情。 1 月 12 日上午， A 股三大股指集体上涨，沪指强势站上 4150 点，沪深两市 半日成交额超 2.3 万亿元，已 连续第 10 个交易日突破 2 万亿元。 截至午间收盘，沪指报 4151.14 点，涨 0.75% ，深证成指涨 1.31% ，创业板指涨 1.17% 。 AI 应用再度爆发 Sora 概念股强势走高 上午， AI 应用再度爆发， Sora 概念股强势拉升，多只概念股涨停。 个股掀 " 涨停潮 " 。其中，流金科技录得 30cm 涨停，拓尔思、易点天下、中文在线均录得 20cm 涨停，博瑞传播、国脉文化、视觉中国等录得 10cm 涨停。 | Sora概念 (文 | 盯盘 | 问财 | | --- | --- | --- | | 名称 | 分时 | 涨幅/现价 | | 流金科技 | | +29.92% | | 920021 | | 9.51 | | 拓尔思 | | +20.02% | | 300229 | | 26.44 | | ...

新华社北京1月12日电（记者李恒）根据国家卫生健康委等6部门12日公布的《医疗卫生机构亡故患者全 流程服务管理规定》，医疗卫生机构应立足主责主业，不得开展殡仪服务。 ...

Core Viewpoint - The Hong Kong stock market's healthcare sector is experiencing significant activity, particularly in brain-computer interfaces and AI healthcare, with notable gains in various stocks and the launch of a new healthcare ETF [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect healthcare sector index has seen a continuous rise, gaining over 1% and marking seven consecutive days of increases since the beginning of 2026 [1]. - Notable stock performances include: - Yimray Sunshine: 8.76% increase, current price at 8.320, market cap of 3.3 billion - Aidi Kang Holdings: 6.81% increase, current price at 5.020, market cap of 3.7 billion - MicroPort Robotics-B: 6.49% increase, current price at 26.900, market cap of 27.7 billion [1]. Group 2: ETF Launch and Characteristics - The newly launched Hong Kong Stock Connect Healthcare ETF (159137) is designed to passively track the healthcare theme index, which includes key sectors such as CXO, AI healthcare, medical devices, and innovative drugs [3]. - The healthcare theme index has demonstrated high elasticity and volatility, with a maximum increase of over 148% during the last healthcare bull market, significantly outperforming comparable indices [3]. Group 3: Recent Developments and Innovations - Recent advancements in brain-computer interfaces and AI healthcare have led to increased attention in the healthcare sector, with OpenAI launching ChatGPTHealth and Neuralink planning large-scale production of brain-computer interface devices by 2026 [4][5]. - Tsinghua University has developed an AI-driven high-throughput drug virtual screening platform, showcasing significant research progress in the field [5]. - The National Medical Products Administration in China is working on standards for medical devices utilizing brain-computer interface technology, indicating a supportive regulatory environment for innovation [5]. Group 4: Investment Opportunities - The A-share market offers investment tools such as the largest healthcare ETF (512170), which includes 12 AI healthcare and brain-computer interface concept stocks, with a combined weight of over 36% [6]. - The current price-to-earnings ratio of the CSI Healthcare Index is 35.46, indicating a favorable valuation compared to historical averages, suggesting potential investment opportunities [6].

Group 1 - The Hong Kong stock market's medical sector remains active, with brain-computer interface and AI medical concepts leading the gains, as evidenced by significant stock price increases for companies like MicroPort Robotics and Alibaba Health [1][8] - The Hong Kong Stock Connect Medical Theme Index has seen a continuous rise for seven days since the beginning of 2026, indicating strong investor interest in the sector [1][8] - The newly launched Hong Kong Stock Connect Medical ETF (Huabao, 159137) is actively trading and aims to passively track the medical theme index, reflecting the growing interest in medical investment tools [1][8] Group 2 - The Hong Kong Stock Connect Medical ETF is anchored on medical innovation, covering key sectors such as CXO, AI medical, medical devices, and innovative drugs, including popular themes like brain-computer interfaces and AI medical [3][11] - The medical theme index has shown high elasticity and volatility, with a maximum increase of over 148% during the last medical bull market, significantly outperforming comparable indices [3][11] Group 3 - Recent developments in the brain-computer interface and AI medical fields have led to increased attention in the medical sector, with notable advancements from companies like Neuralink and research achievements from Tsinghua University [5][13] - Policy initiatives, such as the National Medical Products Administration's plans for standards related to brain-computer interface medical devices, and Beijing's action plan for AI in healthcare, are expected to further stimulate the sector [5][13] Group 4 - Institutional analysis indicates that major overseas pharmaceutical companies are increasing their focus on innovative medical devices in China, suggesting a favorable market environment similar to the previous year's innovative drug sector [6][13] - The A-share medical investment tools, particularly the largest medical ETF (512170), cover a significant portion of AI medical and brain-computer interface stocks, indicating a strong investment opportunity [6][14]

Group 1 - Eddiecon Holdings (09860) saw its stock price rise over 8% in early trading, currently up 6.38% at HKD 5, with a trading volume of HKD 5.2193 million [1] - OpenAI announced the launch of ChatGPT Health, a dedicated space for health-related conversations that integrates with electronic medical records and various health applications, providing responses based on user health information and personal context [1] - Anthropic introduced a new medical service compliant with HIPAA standards for its chatbot Claude, allowing hospitals, healthcare providers, and consumers to handle protected health data, while also enhancing its product with scientific databases and biology research capabilities [1] Group 2 - Domestic AI medical applications are leading, with Ant Group's "Afu" app doubling its monthly active users to 30 million and surpassing 10 million daily inquiries, attributed to its comprehensive service from health consultation to online appointment booking and insurance payment [2] - Eddiecon Holdings launched the "Aixiao Medical" intelligent assistant for doctors, offering a one-stop service that includes testing recommendations, intelligent consultations, report interpretations, and professional Q&A, while also developing a medical AI model "Wenyi" to enhance clinical decision support and multimodal data integration capabilities [2]

数据显示，华宝基金旗下1只基金位居美年健康十大流通股东。华宝中证医疗ETF（512170）三季度减 持1512.18万股，持有股数8866.4万股，占流通股的比例为2.29%。根据测算，今日浮盈赚取约5408.5万 元。 华宝中证医疗ETF（512170）成立日期2019年5月20日，最新规模264.04亿。今年以来收益10.11%，同 类排名457/5579；近一年收益21.65%，同类排名3340/4202；成立以来收益12.09%。 1月12日，美年健康涨9.95%，截至发稿，报6.74元/股，成交1.34亿元，换手率0.51%，总市值263.82亿 元。 资料显示，美年大健康产业控股股份有限公司位于上海市静安区灵石路697号健康智谷9号楼三楼，成立 日期1991年1月22日，上市日期2005年5月18日，公司主营业务涉及健康体检、健康管理业务。主营业务 收入构成为：体检服务95.67%，其他服务4.33%。 从美年健康十大流通股东角度 责任编辑：小浪快报 截至发稿，胡洁累计任职时间13年92天，现任基金资产总规模1002.04亿元，任职期间最佳基金回报 173.62%， 任职期间最差基金回报-98.0 ...